z-logo
open-access-imgOpen Access
Patient Satisfaction with Once-Daily Single-Tablet Darunavir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide (DRV/c/FTC/TAF): A Real-World Study of Patient Self-Reported Outcomes in HIV-1–Diagnosed Adults
Author(s) -
Joyce LaMori,
Antoine Seignez,
L. Radoszycki
Publication year - 2022
Publication title -
patient preference and adherence
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.885
H-Index - 48
ISSN - 1177-889X
DOI - 10.2147/ppa.s332555
Subject(s) - darunavir , medicine , cobicistat , tenofovir alafenamide , emtricitabine , human immunodeficiency virus (hiv) , pharmacology , antiretroviral therapy , family medicine , viral load

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom